Cells in the ciliary epithelium (CE) of the eye can clonally expand in culture to produce spheres of cells that differentiate into retinal neurons and glia. It is believed that these spheres are produced by retinal stem cells (RSCs) and hold promise for cell-based therapies to treat degenerative retinopathies. To improve our understanding of RSC expansion and differentiation, we have carried out a series of preliminary studies on human and mouse CE-derived spheres. Our data have led us to reconsider the current retinal stem cell model and to propose a new hypothesis on the expansion and differentiation of CE-derived cells. We propose that the pigmented CE cells rather than RSCs, expand to form spheres and subsequently transdifferentiate into rods, bipolar cells and Muller glia. This proposal will test if CE-derived spheres form by proliferative expansion of pigmented CE cells or by an RSC mechanism (Aim 1). Culture experiments and in vivo transplantation studies will also be done to test whether pigmented CE cells transdifferentiate into retinal neurons and glia, or if those cells are produced from retinal stem/progenitor cells (Aim 2). Distinction between these 2 hypotheses must be made, because the pathways regulating proliferation and differentiation in retinal stem/progenitor cells differ from those in epithelial cells, and efforts to optimize expansion and differentiation of CE-derived cells must focus on the pathway that reflects that system's biology. The successful completion of these experiments may substantially affect future development of cell-based therapies for millions of people worldwide who suffer from retinal degeneration. This research proposal will also move the RSC field forward by resolving several outstanding questions regarding the proliferation and differentiation of CE-derived cells in culture and in vivo.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY018599-04
Application #
8111837
Study Section
Biology and Diseases of the Posterior Eye Study Section (BDPE)
Program Officer
Neuhold, Lisa
Project Start
2008-08-01
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
4
Fiscal Year
2011
Total Cost
$403,200
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Aldiri, Issam; Xu, Beisi; Wang, Lu et al. (2017) The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis. Neuron 94:550-568.e10
Stewart, Elizabeth; Federico, Sara M; Chen, Xiang et al. (2017) Orthotopic patient-derived xenografts of paediatric solid tumours. Nature 549:96-100
Stewart, Elizabeth; Federico, Sara; Karlstrom, Asa et al. (2016) The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Dev Biol 411:287-293
Hiler, Daniel J; Barabas, Marie E; Griffiths, Lyra M et al. (2016) Reprogramming of mouse retinal neurons and standardized quantification of their differentiation in 3D retinal cultures. Nat Protoc 11:1955-1976
Valle-GarcĂ­a, David; Qadeer, Zulekha A; McHugh, Domhnall S et al. (2016) ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment. Epigenetics 11:398-414
Dyer, Michael A (2016) Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine. Trends Mol Med 22:863-876
Chen, X; Pappo, A; Dyer, M A (2015) Pediatric solid tumor genomics and developmental pliancy. Oncogene 34:5207-15
Stewart, Elizabeth; Shelat, Anang; Bradley, Cori et al. (2015) Development and characterization of a human orthotopic neuroblastoma xenograft. Dev Biol 407:344-55
Pinto, Emilia M; Chen, Xiang; Easton, John et al. (2015) Genomic landscape of paediatric adrenocortical tumours. Nat Commun 6:6302
Langenau, David M; Sweet-Cordero, Alejandro; Wechsler-Reya, Robert et al. (2015) Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer. Cancer Res 75:5176-5186

Showing the most recent 10 out of 34 publications